Extended spectrum beta-lactamases: a therapeutic dilemma.
Patterson
Jan E
JE
Department of Medicine (Infectious Diseases), University of Texas Health Science Center, San Antonio, TX, USA.
D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy*; D015780:Carbapenems / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism*
D015780:Carbapenems; D001618:beta-Lactamases